Synjardy 12.5 mg (Empagliflozin TABLET) 12.5 MG

SYNJARDY 12.5 MG tablets combine empagliflozin and metformin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Strength

12.5 MG

Pack Size

10/60

Manufacturer / TM Owner

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SYNJARDY 12.5 MG tablets are used to help manage type 2 diabetes in adults. This combination medication works by improving blood sugar control, often used alongside diet and exercise. People may ask, 'What is SYNJARDY used for?' It is typically prescribed to lower blood sugar levels in adults with type 2 diabetes.

Side Effects

Common effects of SYNJARDY 12.5 MG tablets may include urinary tract infections, nausea, and diarrhea. Some users might experience dizziness or headache. These effects vary and are not experienced by everyone.

Precautions & Warnings

SYNJARDY 12.5 MG tablets should be handled with care. It is important to follow the advice of a healthcare provider regarding its use. People with certain medical conditions or allergies should discuss these with their healthcare provider before starting this medication.

Avoid Interactions

SYNJARDY 12.5 MG tablets may interact with other medications, including certain diabetes drugs and diuretics. Alcohol consumption should be discussed with a healthcare provider, as it can affect blood sugar levels. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

SYNJARDY 12.5 MG tablets are used to help manage type 2 diabetes in adults by improving blood sugar control.

SYNJARDY 12.5 MG tablets are taken orally, typically once or twice daily, as directed by a healthcare provider.

Common side effects may include urinary tract infections, nausea, diarrhea, dizziness, and headache.

SYNJARDY may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

SYNJARDY should be used with caution in people with certain medical conditions or allergies, and a healthcare provider should be consulted.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.